These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 36704514

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients.
    Li H, Gui H, Yuan G, Zheng X, Gao C, Yuan H.
    Scand J Clin Lab Invest; 2018 Jul; 78(4):269-274. PubMed ID: 29553861
    [Abstract] [Full Text] [Related]

  • 3. Expression level and clinical significance of LncRNA PVT1 in the serum of patients with LEASO.
    Su X, Yuan X, Li F, Yang G, Du L, Zhao F, Zhao R, Ou M.
    PeerJ; 2023 Jul; 11():e16057. PubMed ID: 37744231
    [Abstract] [Full Text] [Related]

  • 4. [Correlation between C-reactive protein to albumin ratio and restenosis after femoral popliteal stenting in patients with lower extremity arteriosclerotic obliterans].
    Wang YM, Zhang MQ, Chen ZP, Ji R, Cai J, Qiao T.
    Zhonghua Wai Ke Za Zhi; 2023 Dec 01; 61(12):1058-1064. PubMed ID: 37932141
    [Abstract] [Full Text] [Related]

  • 5. Effect of diabetes on the prognosis, serum inflammatory factors, and quality of life of patients with lower extremity arteriosclerosis obliterans after vascular intervention: a retrospective comparative cohort study.
    Zhao H, Zhuo T, Hao X, Fan X, Zhao P.
    Ann Palliat Med; 2022 Aug 01; 11(8):2720-2729. PubMed ID: 36064362
    [Abstract] [Full Text] [Related]

  • 6. Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans.
    Lian W, Nie H, Yuan Y, Wang K, Chen W, Ding L.
    J Invest Surg; 2021 Jul 01; 34(7):765-770. PubMed ID: 31996054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors.
    Xiao D, Song J.
    Comput Math Methods Med; 2022 Jul 01; 2022():9190292. PubMed ID: 35966252
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Risk factor analysis on body mass rebound after laparoscopic sleeve gastrectomy and establishment of a nomogram prediction model].
    Zhao J, Jiao YW, Qian J, Qian ZF, Yang HJ, Tang LM.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Oct 25; 25(10):913-920. PubMed ID: 36245117
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Significance of high mobility group box 1, von Willebrand factor and other cytokines in the evaluation of severity and prognosis of sepsis patients].
    Chen Y, Huang X, Kong G, Liu X, Tian H, Lyu B, Ning F, Wang T, Hao D.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug 25; 32(8):933-937. PubMed ID: 32912405
    [Abstract] [Full Text] [Related]

  • 15. Humanistic care interventions in patients with lower extremity arteriosclerosis obliterans.
    He Y, Xie C, Xia Y, Rang J, Peng L.
    Am J Transl Res; 2021 Aug 25; 13(9):10527-10535. PubMed ID: 34650723
    [Abstract] [Full Text] [Related]

  • 16. Effect of alprostadil plus cilostazol on the treatment outcomes and inflammatory factors in patients with lower extremity arteriosclerosis obliterans receiving evidence-based care.
    Liang H, Liu P, Yang M, Di P, Wu W, Li H, Liu Y.
    Clin Hemorheol Microcirc; 2024 Aug 25; 87(4):405-413. PubMed ID: 38848169
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease.
    Yu ZH, Wang HT, Tu C.
    Eur J Med Res; 2017 Jan 05; 22(1):2. PubMed ID: 28057086
    [Abstract] [Full Text] [Related]

  • 19. Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.
    He W, Xu C, Wang X, Lei J, Qiu Q, Hu Y, Luo D.
    BMC Cardiovasc Disord; 2021 Sep 14; 21(1):435. PubMed ID: 34521385
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.